• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, June 27, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

UTHSC’s Neil Hayes, MD, funded to continue research related to the cancer genome atlas

Bioengineer by Bioengineer
September 15, 2021
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Neil Hayes, MD, MPH, director of the Center for Cancer Research at the University of Tennessee Health Science Center, is one of two principal investigators for a $1.8 million grant that extends the work of The Cancer Genome Atlas (TCGA), a groundbreaking multisite project to understand cancer at its molecular level through genome sequencing and extensive data analysis.

UTHSC’s Neil Hayes, MD, Funded to Continue Research Related to The Cancer Genome Atlas

Credit: The University of Tennessee Health Science Center

Neil Hayes, MD, MPH, director of the Center for Cancer Research at the University of Tennessee Health Science Center, is one of two principal investigators for a $1.8 million grant that extends the work of The Cancer Genome Atlas (TCGA), a groundbreaking multisite project to understand cancer at its molecular level through genome sequencing and extensive data analysis.

The grant from the National Cancer Institute, which extends over five years, is a computational grant to continue to analyze the genetics of cancers, with many of the cases coming from patients treated in some of the most-important recent clinical trials, Dr. Hayes said. In this way, the new project advances the research beyond identification toward understanding interactions of cancer genetics and therapeutics, as measured through the samples.

Dr. Hayes, division chief of Hematology and Oncology at UTHSC, shares co-principal investigator duties with Katherine A. Hoadley, PhD, assistant professor at the University of North Carolina at Chapel Hill. The total funding for the project is split equally between the two universities.

“This is the most-recent version of cancer genomics projects directly descended from TCGA,” said Dr. Hayes, who was one of the investigators on The Cancer Genome Atlas, which began in 2006 and formally ended in 2018. A flagship team science effort of the National Institutes of Health and the National Human Genome Research Institute, The Cancer Genome Atlas has published findings identifying genomic changes or mutations in cells of 33 types of cancer by analyzing more than 20,000 specimens. Researchers from a dozen or more institutions across the country built a network to complete the project, and have published their findings in more than 200 papers in prestigious scientific journals.

Dr. Hayes, the Van Vleet Endowed Professor in Medical Oncology at UTHSC, was a leader of a site at the University of North Carolina that conducted the sequencing of RNA, which controls abnormal genetic expressions in cancer cells. He was recruited to UTHSC in 2017. More than 15 years after his original work on the TCGA, he remains enthusiastic about the continued potential of cancer genomics in patient health.

“In the beginning, we were really out in the wilderness as far as the cancer genome,” Dr. Hayes said. “We were describing all kinds of abnormalities in human tissues that had transformed from normal to cancer. In many ways, it was a process of generating a list of all the ways in which a normal cell could go wrong. With more-recent versions of TCGA, including the one we were just awarded, we have more of an opportunity to take the lessons of the last 15 years and see how each of those abnormalities explains why some patients respond to cancer treatments and others do not.”

###



Share12Tweet8Share2ShareShareShare2

Related Posts

Kytai Nguyen

Nanomaterials that provide imaging while delivering medication

June 24, 2022
Oncotarget's Volume 13

Oncotarget | New oncology-focused papers published in Volume 13

June 23, 2022

Scientists use human breast milk to treat prolonged COVID-19 in a severely immunodeficient patient

June 23, 2022

How MRI and CT predict flap failure after head and neck reconstructive cancer surgery

June 23, 2022

POPULAR NEWS

  • Pacific whiting

    Oregon State University research finds evidence to suggest Pacific whiting skin has anti-aging properties that prevent wrinkles

    37 shares
    Share 15 Tweet 9
  • University of Miami Rosenstiel School selected for National ‘Reefense’ Initiative focusing on Florida and the Caribbean

    35 shares
    Share 14 Tweet 9
  • Saving the Mekong delta from drowning

    37 shares
    Share 15 Tweet 9
  • Sharks may be closer to the city than you think, new study finds

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

UrbanizationVirusUniversity of WashingtonZoology/Veterinary ScienceWeaponryViolence/CriminalsVaccinesVaccineUrogenital SystemWeather/StormsVehiclesVirology

Recent Posts

  • Who’s really in control?
  • Third and fourth robotic arms feel like a part of the user’s own body
  • Novel, sensitive, and robust single-cell RNA sequencing technique outperforms competition
  • Ancient microbes may help us find extraterrestrial life forms
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....